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©The Diabetes Primary Prevention
Initiative Interventions Focus Area
A Case Study and Recommendations
Deborah S. Porterfield, MD, MPH, Laurie Hinnant, PhD, David M. Stevens, MD,
Ernest Moy, MD, MPH, the DPPI-IFA Case Study Group
Background: In 2005, CDC began the Diabetes Primary Prevention Initiative Interventions Focus
Area (DPPI-IFA), which funded fıve state Diabetes Prevention and Control Programs (DPCPs) to
translate diabetes primary prevention trials into real-world settings by developing and implementing
a framework for state-level diabetes primary prevention.
Purpose: The purpose of this case study, conducted in 2007, was to describe DPPI-IFA implemen-
tation, including facilitators and challenges to the initiative.
Methods: Case studies of the fıve DPCPs in the DPPI-IFA involving site visits with key informant
interviews of state staff and partners and archival record collection.
Results: Partners recruited for DPPI-IFA activities included local or state public health agencies
(three of fıve DPCPs); regional or state nonprofıt organizations (fıve DPCPs); businesses or employ-
ers (threeDPCPs); and healthcare organizations (fourDPCPs). TheDPCPs implemented a variety of
interventions in three main domains: diabetes primary prevention and prediabetes awareness,
screening activities and lifestyle interventions, and prediabetes-related health policy efforts. Prelim-
inary outcomes are described at the individual and organization/partnership levels. Results suggest
the importance of utilizing preexisting partnerships to extend work into diabetes prevention, pro-
viding even small amounts of funding to partners, and prior program planning for diabetes preven-
tion. Challenges for the DPPI-IFA included recruiting participants, establishing links with providers
to obtain diagnostic testing for people screened for prediabetes, and offering a lifestyle intervention.
Conclusions: The DPPI-IFA represents a unique effort by state public health programs in the
translation of diabetes primary prevention trials into real-world settings. The experiences of the
DPPI-IFA programs offer valuable lessons for future community-based diabetes prevention initia-
tives, especially regarding the need to strengthen clinical–community partnerships for referral of
people with prediabetes to evidence-based lifestyle programs.
(Am J Prev Med 2010;39(3):235–242) © 2010 American Journal of Preventive MedicineI
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n the U.S., nearly 30% of adults have prediabetes
(defıned as impaired fasting glucose [IFG] or im-
paired glucose tolerance [IGT]).1 People with these
onditions have a fıve to 15 times greater risk of develop-
ng diabetes than people with normal blood glucose.2
rom RTI International (Porterfıeld, Hinnant), Research Triangle Park,
orth Carolina; George Washington University (Stevens); and Agency for
ealthcare Research and Quality (Moy), Washington, DC
Additionalmembers of theDPPI-IFACase StudyGroup are listed in the
cknowledgments section at the end of the text.
Address correspondence to: Deborah S. Porterfıeld, MD, MPH, RTI
nternational, 3040 Cornwallis Road, Research Triangle Park NC 27709-
194. E-mail: dporterfıeld@rti.org.a
0749-3797/$17.00
doi: 10.1016/j.amepre.2010.05.005
2010 American Journal of Preventive Medicine. All rights reserved.mportantly, there is fırm consensus that intensive life-
tyle interventions can delay or prevent the onset of dia-
etes in people with prediabetes3–7 and that screening
nd lifestyle interventions are cost effective.6–9
Preventing the burden of diabetes by detecting and
ntervening in peoplewith prediabetes, however, requires
ranslation of clinical trials into real-world settings.10–12
ublic health agencies play an important role in the trans-
ation of diabetes prevention trials through a variety of
echanisms, including promoting the adoption of
creening guidelines in healthcare settings,13 developing
ommunity-based interventions, and linking providers
o existing interventions. Yet “many public health areas
elevant to diabetes have been relatively underexplored
nd understudied.”10
Am J Prev Med 2010;39(3)235–242 235
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236 Porterfıeld et al / Am J Prev Med 2010;39(3):235–242In 2005, the CDC’s Division of Diabetes Translation
egan theDiabetes Primary Prevention Initiative (DPPI),
hich built on previous public health diabetes prevention
rojects.14,15 The Interventions Focus Area (IFA) com-
onent of the DPPI funded fıve state Diabetes and Pre-
ention Control Programs (DPCPs) in California, Mas-
achusetts, Michigan, Minnesota, and Washington to
evelop, implement, and disseminate a framework for
tate-level primary prevention programs targeting people
ith prediabetes. States were given maximum flexibility
o identify and implement interventions across the broad
pectrum of activities normally conducted by DPCPs
health communications, health systems interventions,
nd community interventions and policy initiatives). At
he same time that DPCPs piloted their own state-based
nitiatives, they also worked together in an ongoing fash-
on to develop a framework and other materials that
ould guide other DPCPs in future efforts.
In 2007, the CDC and the Agency for Healthcare Re-
earch and Quality (AHRQ) contracted with RTI Inter-
ational to develop a descriptive case study of the fıve
tates participating in DPPI-IFA. The purpose of the
resent study was to describe the implementation of dia-
etes primary prevention programs in the fıve states, with
n explicit intent to identify and disseminate lessons
earned, resources, and tools to inform future efforts of
DC, the additional 54DPCPs in all states and territories,
nd other public health and clinical stakeholders. This
anuscript describes the key fındings of the case study,
rovides recommendations to CDC and DPCPs for fur-
her efforts, andprovides recommendations toother clinical
r public health organizations attempting to translate the
iabetes prevention clinical trials into real-world settings.
ethods
he case study design was influenced by CDC’s “Framework for
rogram Evaluation in Public Health”16 and key qualitative re-
earch authors.17,18 The work was also guided by a Steering Group
f representatives from CDC, AHRQ, and state DPCPs who fo-
used the case study; gave extensive input to the design of case
tudy questions (Table 1) andmethods; and reviewed the fınal case
tudy report. RTI’s IRB reviewed the proposed work and deter-
ined it to be exempt from review.
RTI reviewed program documents from each state, developed
nd completed state-specifıc Program Summary Forms (PSF), and
onducted face-to-face and telephone interviews. From July
hrough September 2007, RTI conducted fıve 2-day site visits, with
total of 29 interviews involving 57 people (14 DPCP staff, 6 other
tate health department staff, and 37 partners). These site visits
ncluded key informant interviews and additional archival record
ollection. The interview guides were developed based on the case
tudy questions and consisted of open-ended, semistructured
uestions. A combined purposive and snowball sampling strategy
as used to identify key informants beyond program staff with a naximum of 12 interviews per site visit, in groups no larger than
hree people. State DPCPs were given two opportunities to provide
pdated information to capture work conducted since the original
ata collection in summer 2007, including 5 additional interviews
ith DPCP staff in April and May of 2008.
Two separate analyses—individual case studies and a cross-site
ase study—were conducted. Because the case study was largely
escriptive in nature, extensive a priori coding structure was not
sed; rather, data were analyzed around case study questions.
here appropriate, common themes were identifıed and used as
oosely defıned codes both within and across states. The analyses
ncluded an in-depth review of the PSF, annual budgets, program
ocuments, and notes and recordings of each interview. After
nalyses were completed and a site summarywas drafted, each case
tudy team member reviewed the summary for accuracy. For the
ross-site case study, results are organized around fıve major areas:
artnerships, interventions, outcomes, facilitators, and challenges.
esults
escription of the Partners and Partnerships
entral to DPPI–IFA activities was identifıcation of ca-
able partners and establishment and maintenance of
trong partnerships (Table 2). Three of fıve DPCPs part-
able 1. DPPI-IFA case study questions
Level Overarching questions
Structure What are the intervention designs?
Are interventions consistent with best
practices and available evidence?
What types of support were most helpful to
the pilot states in facilitating
implementation of this program?
What have been the resources needed for
planning and implementing the program?
What are the states doing to institutionalize/
sustain the programs?
Process How do the programs recruit and retainpartners?
What are partners doing to meet the DPPI
objectives?
How do the programs involve partners once
they are on board?
What tools have been developed or used by
states?
Outcome What are the programs accomplishing?
What are accomplishments at the participant
level?
What are the accomplishments at the
community/organizational level?
PPI-IFA, Diabetes Primary Prevention Initiative Interventions Focus
reaered with local or state public health agencies, all fıve
www.ajpm-online.net
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Sable 2. Primary and secondary DPPI-IFA partners, by funded state
DPPI-IFA state Intervention description Partners
California Worksite screening and lifestyle
interventions with a primary partner (a
healthcare system and its associated
foundation) and two additional
employers
Healthcare system and its associated foundation
Employers:
Newspaper
Bank
Healthcare system
Clinic-based screening in a healthcare
system
Healthcare system and its associated foundation
Massachusetts Worksite screening and lifestyle
intervention for staff employed at a
local manufacturing facility in
conjunction with a community-based
diabetes nonprofit organization
Community-based diabetes nonprofit organization
Employer: lighting manufacturer
Hospital
Trainings for employers on worksite health
improvement
A regional worksite health improvement initiative,
including employers and other state agencies
Michigan Pilot program in a local health department
WISEWOMAN program implementing
diabetes and prediabetes screening
and lifestyle intervention
Michigan WISEWOMAN program
A local health department WISEWOMAN program
Pilot screening and lifestyle intervention
program involving one local health
department WISEWOMAN program
and a local YMCA
A local health department WISEWOMAN program
A local YMCA
A training for WIC providers on gestational
diabetes and development of nutrition
care plans for these clients
Michigan WIC program
Support for a regional diabetes initiative Regional diabetes initiative (led by a health plan
and a healthcare system)
A screening program in community
locations led by a regional diabetes
outreach network
TIPDON
Minnesota Support for the development and release
of statewide prediabetes screening
and treatment guidelines
Statewide diabetes steering committee
Statewide clinical guideline development
organization
Newspaper and TV media to increase
prediabetes awareness
Minnesota Diabetes Collaborative
Statewide diabetes steering committee
State public health genomics program
American Diabetes Association (Minnesota)
A multisite screening and lifestyle
intervention (I CAN Prevent Diabetes)
involving local Steps programs,
clinics, and YMCAs
Steps to a Healthier Minnesota (and local Steps
programs in Rochester, St. Paul, Willmar, and
Minneapolis)
Four clinics
Two YMCAs and one parks and recreation center
Washington A screening program in a rural hospital
district for prediabetes incorporated
into an existing health risk
assessment for county employees
A rural hospital district
A collaboration with REACH organizations
in Seattle to conduct screenings in
three community-based health clinics
or organizations, all of which serve
racial and ethnic minorities
REACH Seattle
Three community-based clinical/health
organizations
PCPs, Diabetes Prevention and Control Programs; DPPI-IFA, Diabetes Primary Prevention Initiative Interventions Focus Area; I CAN Prevent
iabetes, Individuals and Communities Acting Now to Prevent Diabetes; REACH, racial and ethnic approaches to community health; TIPDON,
orthern Michigan’s Diabetes Outreach Network; WIC, U.S. Department of Agriculture’s Special Supplemental Nutrition Program for Women,
nfants, and Children; WISEWOMAN, Well-Integrated Screening and Evaluation for Women Across the Nation
eptember 2010
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238 Porterfıeld et al / Am J Prev Med 2010;39(3):235–242PCPs partnered with regional or state nonprofıt orga-
izations, three partnered with businesses or employers,
nd four partnered with healthcare organizations. Pri-
ary partners worked directly with DPCPs on design or
mplementation of interventions, whereas secondary
artners worked closely with primary partners but had
ittle direct interaction with DPCPs. For example, in
ne state, the health department partnered with a local
ommunity-based diabetes organization, which in turn
artnered with a hospital and a business to conduct a
orksite screening.
Across all fıve states, three key themes emerged regard-
ng reasons state DPCPs recruited partners for this work:
revious experience or work with DPCP or DPCP staff,
ccess to target audience, and previous experience in the
rea of intervention. Almost all DPPI-IFA states utilized
xisting organizational or personal relationships to iden-
ify potential partners for implementation of their DPPI-
FA interventions. In many cases, DPCPs were able to
apitalize on their relationships with other state health
epartment programs to integrate diabetes primary pre-
ention and prediabetes screening into other areas of
ork.Many partnerswere selected because they provided
ccess to high-risk target groups; for example, Well-
ntegrated Screening and Evaluation of Women Across
heNation (WISEWOMAN);Women, Infants, andChil-
ren (WIC); and Racial and Ethnic Approaches to Com-
unity Health (REACH).
Partners’ reasons for participating included that the
PPI-IFA interventions were in line with their organiza-
ional priorities and were a natural fıt with their organi-
ations’ existing work. Having even relatively modest
esources available was enough for several DPCPs and
rganizations to initiate a partnership.
escription of the Interventions
he DPCPs implemented a variety of interventions in
hree main domains: diabetes primary prevention and
rediabetes awareness, screening activities and lifestyle
nterventions, and prediabetes-related health policy.
iabetes primary prevention and prediabetes aware-
ess interventions. Educating and raising awareness of
rediabetes was a priority for many programs; the fıve
PCPs implemented fıve interventions in provider
wareness and three in public awareness. Educational
ctivities were conducted for providers as part of some
creening programs to prepare them to diagnose and
reat individuals with prediabetes identifıed by the com-
unity-based screening, and in one state a statewide
ducational training on gestational diabetes and nutri-
ion care plan materials were developed for WIC provid-
rs. For the general population, another state conducted veveral awareness-raising campaigns around family his-
ory of diabetes as a risk factor for diabetes and diabetes
rimary prevention.
creening activities and lifestyle interventions. All
ıve DPCPs implemented some type of screening compo-
ent for theirDPPI-IFA intervention,with threeworksite
nterventions, three health system interventions, two in-
erventions in health departments, and four in other set-
ings. One feature of the DPPI-IFA was that screening
rograms generally took place in a community or non-
linical setting, diagnosis took place in a provider’s
ffıce or another clinical setting, and interventions
ere placed once again in the community. This neces-
itated linkages and information flow between the pub-
ic health/community organizations and clinical pro-
iders. Community-based screenings took place in health
airs and other community settings, such as Laundro-
ats, food pantries, and free clinics. Another state imple-
ented two screening pilots in local health department
ettings through their existing WISEWOMAN program.
inally, two states implemented screening in providers’
ffıces, either in a network of clinical sites in partnership
ith local Steps to a HealthierUS programs or within a
ealthcare system.
The linkages between screening activities outside clin-
cal settings and a formal diagnosis of prediabetes in a
linical setting varied signifıcantly across interventions.
mportantly, DPCPs were almost universally aware that
aving a referral source for people was critical before
mplementing a community-based screening interven-
ion. Resources and strategies to accomplish this varied
reatly across locations; screened participants in one
ommunity-based program were told to visit their pri-
ary care provider for diagnosis, whereas participants in
worksite intervention had access to a clinical team and
in-house” oral glucose tolerance testing (OGTT). Other
nterventions relied on existing referral networks, which
t times were strengthened by activities of the DPCP or
artner staff.
In the majority of screening interventions, OGTT,
onducted in a provider’s offıce, was recommended as the
iagnostic test of choice. However, screening programs
sed a variety of tests to identify people at high risk for
rediabetes and requiring in-offıce, OGTT diagnosis.
hese included the ADApaper risk test, a paper screen or
omputer algorithm using National Diabetes Education
rogram (NDEP) criteria for prediabetes screening, ran-
om capillary glucose tests, and fasting capillary glucose
ests. Three of the fıve states had developed a formalized,
ocumented screening algorithm. Most states acknowl-
dged the importance of tracking and follow-up of indi-
iduals screened; two states tracked people screened and
www.ajpm-online.net
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Sonducted follow-up, one using a paper system and one a
omputer database.
Most of the screening activities were paired with life-
tyle interventions for those identifıed as high risk for or
aving prediabetes. Interventions were offered at work-
ites; in community settings; at YMCAs; and, for one
ealthcare system initiative, as part of their weight man-
gement program. Almost all the interventions were de-
cribed as being adapted from the Diabetes Primary Pre-
ention (DPP) curriculum.3,4 This tailoring of the DPP
urriculum resulted in a shorter (hours and sessions)
reatment intervention. In addition to health education in
group setting, features of the interventions included
ne-on-one sessions with a lifestyle coach, weekly weigh-
ns, or a free 4-month membership to a local gym. The
umber of contact hours per participant ranged fromone
isit to 16 hours. Most interventions were free for the
articipants. Although designed for people with predia-
etes, the lifestyle interventions in the three states that
ad results at the time of data collection each included
articipants either whose status was not known or who
ere known to not have prediabetes.
rediabetes-related health policy. Across the fıve
PCPs, there were three health policy interventions in
ealth systems, two in health departments, and three in
ther settings. One state worked extensively in diabetes-
elated health policy, by partnering with a state-based clini-
al guideline–making body of medical groups, hospitals,
nd health plans to strengthen references to prediabetes
ithin the contextof twoexistingguidelines and to contrib-
te to a new primary prevention of chronic disease guide-
ine. In another state, policy-level work included institu-
ionalizing diabetes and prediabetes screening into the
ISEWOMAN program and working to have prediabe-
es detection activities included in a regional diabetes
nitiative led by a health plan and healthcare system.
reliminary Outcomes of the Interventions
he purpose of the present case studywas descriptive, not
valuative, and a description of results relies on the eval-
ations conducted by the DPCPs as well as information
ollected in the case study interviews. Several states col-
ected process and impact measures, whereas others were
ess engaged in evaluation activities. In general, relatively
ittle data were available on the implementation or out-
omes of activities other than the screenings for
rediabetes.
rganizational and community level. Across the state
PCPs, there is evidence that some interventions have
een institutionalized and will continue after funding
nds. These include screening and lifestyle interventions
ncorporated in one state’s WISEWOMAN program af- 9
eptember 2010er a successful pilot in one county, the WIC nutrition
are plan incorporated into one state’s manual and stan-
ard protocols, and the prediabetes screening that was
ncorporated into a countywide health promotion cam-
aign. The clinical guidelines in one state, expanded to
ncorporate prediabetes, also represent a major potential
olicy force.
Some evidence suggests that prediabetes programming
as become institutionalized within the DPCPs and will
ontinue even without future dedicated funding. An ad-
itional outcome of note is the enhanced expertise or
apacity of DPCPs and partners to work in prediabetes or
onduct specifıc interventions.
ndividual level. Summarizing individual-level out-
ome results of the DPPI-IFA is challenging because
ata were unavailable or incomplete at the time of data
ollection and because different screening and diagno-
is strategies were used across sites. This paper sum-
arizes available data from three worksite interven-
ions in two states, the WISEWOMAN screening pilot
n a third state, and community-based screening initi-
tives in a fourth.
each. The worksite interventions had potential to
each large numbers of people (from 600 to 6,000); the
nterventions did reach from 1% to 18% of employees.
he WISEWOMAN pilot had a potential reach of 250
articipants. The community-based screenings had an
nknown number of potential participants.
ield. In one state with two different worksite screen-
ngs, more than 80% of people were classifıed as at risk
nd recommended for OGTT testing based on NDEP
riteria. In the second of these screenings, approximately
5% of people referred to OGTT were ultimately diag-
osed with prediabetes. In two other states, which used
apillary fasting tests, approximately one quarter to one
hird of people screenedhad a blood glucose level over the
utoff of 100 mg/dL. Unfortunately, no additional data
re available on the diagnoses (yield) of prediabetes from
hese groups.
nrollment in interventions. It is not possible to assess
hether enrollment of people with prediabetes into the
nterventions was successful, because interventions were
enerally open to people who signed up for screening,
egardless of their risk status or screening results, and
ecause of the limitations of the tracking systems em-
loyed. In one state, 80% of those referred for the inter-
ention did enroll.
ntervention completion. Two states reported data on
ntervention completion, reporting high levels (87% and
5%).
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240 Porterfıeld et al / Am J Prev Med 2010;39(3):235–242utcomes of the interventions. The screening pro-
rams that included a lifestyle intervention resulted in
odest, but potentially meaningful, weight loss. One in-
ervention reported an averageweight loss of 3.6% (n14
eople); the second reported an average weight loss of
.3% (n14); and the third reported an average weight
oss of 0.1% (n33).
acilitators of Success
everal respondents commented that utilizing existing
artnerships was integral to the implementation of
nterventions. Often DPCPs developed strong working
elationships with new partners; elements that made
hese new relationships effective include identifying
apable lead people within the partner organization
nd having a common organizational goal to address
rediabetes.
An additional facilitator of success reported by sev-
ral DPCPs was the ability to provide even minimal
unding to partners to implement activities. Finally,
hree states hadparticipated inpreviousdiabetes prevention
lanning work,14,15 which helped them develop ideas for
iabetes primary prevention projects as part of the
PPI-IFA.
hallenges
lthough all DPPI-IFA DPCPs and partners described
heir work with DPPI-IFA as a success, they also ac-
nowledged many challenges. Challenges specifıc to the
PPI-IFAwere the level of DPPI-IFA funding to DPCPs;
he nature of the funding (uncertain levels of funding
ear-to-year); and the tight timeline within which inter-
entions were to be implemented.
Other challenges are generalizable to community-
ased diabetes prevention programs. In the screening
hase of interventions, the variety of screening tests avail-
ble and slightly varying published algorithms13,19 pre-
ented a challenge for DPCPs and partners. States reported
pending a substantial amount of time investigating vari-
us tests and designing screening protocols, which de-
reased the time available to identify or develop lifestyle
ntervention programs. Also, recruitment of participants
as a challenge for several states, andworksites presented
nique implementation challenges. Both states with
orksite interventions needed to develop strategies that
ould allow for inclusion of participants working differ-
nt shifts, while not disrupting productivity. Finally, es-
ablishing strong links between the public health or com-
unity organizations and primary care providers,
nsuring that referral appointments were kept, and ob-
aining diagnostic test results were notable challenges for
everal states. Intervention staff received diagnostic in- iormation for between 3% and 100% of patients. This
ndicates suboptimal integration in some cases between
he primary care delivery system and public health.
In the intervention phase, implementing the DPP cur-
iculum as designed was too burdensome, but two states
oted that adapting the DPP curriculum was also a chal-
enge in terms of time and resources required. Programs
lso found it challenging to identify enough people with a
iagnosis of prediabetes to fıll capacity in the lifestyle
nterventions because of the tight timeline, low numbers
f people recruited, and delays in getting reports back
rom providers. As a result, people with an unknown
tatus or who were known to not have prediabetes were
nrolled in the classes.
A fınal challenge related to the technical aspects of
racking participants and the need for data systems. All
rograms did follow lifestyle intervention participants,
lthough not all programs tracked screened participants.
rograms commented that some partner staff lacked ex-
eriencewith data collection or computer skills necessary
o maintain the data.
iscussion
or the past 3 years, the DPPI-IFA has challenged state
PCPs to develop novel interventions in diabetes pri-
ary prevention in order to translate research fındings of
linical trials into real-world settings. The current case
tudy was designed to provide a midcourse snapshot of
hese pilot interventions, their implementation, and early
utcomes, and to inform CDC and future diabetes pri-
ary prevention efforts by other DPCPs.
The major limitation of the present case study is that it
as conducted while DPCPs were still in the implemen-
ation phase of their interventions. Thus, it cannot be
onsidered a fınal description of their work. In addition,
he current case study was not intended as an evaluation.
ny fındings or recommendations that extend beyond a
escription of the fıve state interventions deserve further
xploration.
Although each DPCP in the DPPI-IFA tackled only
ne of a few interventions, together the fıve DPCPs con-
ributed to policy, organizational, and individual change.
n addition to the individual successes of each state, as a
ilot initiative, the DPPI-IFA met its goal of furthering
he translation of clinical trials in diabetes primary pre-
ention to community-based health and public health
ettings. The present case study complements other re-
orts emerging fromcommunity-based projects20–22; the
PPI-IFA is unique, however, in terms of having state
ublic health entities in the role of disseminators or facil-
tators of such projects.
www.ajpm-online.net
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SThe DPPI-IFA illustrates many of the challenges pre-
iously described in translating diabetes prevention sci-
nce into public health practice. These include deciding
n the target population for intervention and the screen-
ng tests to be used to identify them; integrating health-
are and public health systems; designing the lifestyle
nterventions, including who should deliver them and
here they should occur; understanding the need for
nterventions to be intensive and sustained in nature; and
etermining who should pay.11,15,23,24 The DPPI-IFA
lso demonstrates the challenges of establishing effective
inkages between public health or community organiza-
ions and primary care.25,26
The specifıc challenges of the DPPI-IFA programs of-
er valuable lessons in terms of recommendations for
DC or other funders, DPCPs or other public health
rograms attempting to translate clinical trials into real-
orld settings, and other partners or stakeholders (Table
). For funders such as CDC, it is critical to provide
uffıcient and sustained funding and to provide suffıcient
echnical assistance, in the case of the DPPI-IFA to help
rantees to understand and translate technical aspects of
ommunity-based screening (which tests to use, how to
rack participants) and lifestyle interventions (how to
dapt the DPP curriculum).
ForDPCPs andother public health programs, there are
able 3. Recommendations for funders, public health pro
CDC or other funders Provide sustained and suffic
Provide sufficient time for p
Provide appropriate technica
people at risk for pred
Conduct a comprehensive e
effectiveness analysis
and awareness interve
Reconsider the feasibility of
DPCPs or other public health
programs
Maximize existing relationsh
For screening and lifestyle i
Consider a prolonged awa
Evaluate and adopt existi
Allocate sufficient staff an
Ensure clinical referrals a
Consider offering an educ
Adopt existing interventio
Track people recruited an
evaluation.
Strengthen evaluation by
evaluator).
Recognize that partners m
systems.
Look for potential policy or
clinical interventions.
Other partners/stakeholders Recognize the important co
secondary partners that w
Seek necessary technical a
PCPs, Diabetes Prevention and Control Programs; DPPI-IFA, Diabetumerous lessons learned from the variety of clinical i
eptember 2010nterventions of the DPPI-IFA, which address increasing
each of the interventions (e.g., implementing prolonged
ducational phases prior to recruitment); increasing
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